Naproxen
- Product NDC
- 43353-201
- 11-digit product format
- 433530201
- Labeler code
- 43353
- Product ID
- 43353-201_9d397bfd-f53e-42ca-8e0f-5392b6324e15
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA091305
- Marketing category
- ANDA
- Marketing start
- 2012-01-23
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-201 | NAPROXEN TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20160714_84ee4538-e051-4a6e-b961-c1a40ca09d1b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-201-70 | 43353020170 | 120 TABLET in 1 BOTTLE (43353-201-70) | 120 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |